| Issue Date | Title | Author(s) |
| 2019-11-01 | The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial | Hewson, EA; Nguyen, DT; O’Brien, R; Kim, JH; Montanaro, T; Moodie, T; Greer, PB; Hardcastle, N; Eade, T; Kneebone, A; Hruby, G; Hayden, AJ; Turner, S; Siva, S; Tai, KH; Hunter, P; Sams, J; Poulsen, PR; Booth, JT; Martin, J; Keall, PJ |
| 2018-06-01 | Acupuncture in Oncology: The Effectiveness of Acupuncture May Not Depend on Needle Retention Duration | Oh, B; Eade, T; Kneebone, A; Hruby, G; Lamoury, G; Pavlakis, N; Clarke, S; Zaslawski, C; Marr, I; Costa, D; Back, M |
| 2020-10 | Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial. | Hewson, EA; Nguyen, DT; O'Brien, R; Poulsen, PR; Booth, JT; Greer, P; Eade, T; Kneebone, A; Hruby, G; Moodie, T; Hayden, AJ; Turner, SL; Hardcastle, N; Siva, S; Tai, KH; Martin, J; Keall, PJ |
| 2016-09-01 | Oxidative stress in prostate cancer patients: A systematic review of case control studies | Oh, B; Figtree, G; Costa, D; Eade, T; Hruby, G; Lim, S; Elfiky, A; Martine, N; Rosenthal, D; Clarke, S; Back, M |
| 2013-11-01 | The prevalence and correlates of supportive care needs in testicular cancer survivors: A cross-sectional study | Smith, A; King, M; Butow, P; Luckett, T; Grimison, P; Toner, GC; Stockler, M; Hovey, E; Stubbs, J; Hruby, G; Gurney, H; Turner, S; Alam, M; Cox, K; Olver, I |
| 2016-04-01 | The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study | Smith, AB; Butow, P; Olver, I; Luckett, T; Grimison, P; Toner, GC; Stockler, MR; Hovey, E; Stubbs, J; Turner, S; Hruby, G; Gurney, H; Alam, M; Cox, K; King, MT |
| 2020-07 | Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial. | Keall, P; Nguyen, DT; O'Brien, R; Hewson, E; Ball, H; Poulsen, P; Booth, J; Greer, P; Hunter, P; Wilton, L; Bromley, R; Kipritidis, J; Eade, T; Kneebone, A; Hruby, G; Moodie, T; Hayden, A; Turner, S; Arumugam, S; Sidhom, M; Hardcastle, N; Siva, S; Tai, K-H; Gebski, V; Martin, J |
| 2023-08-21 | The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy. | Roberts, MJ; Conduit, C; Davis, ID; Effeney, RM; Williams, S; Martin, JM; Hofman, MS; Hruby, G; Eapen, R; Gianacas, C; Papa, N; Lourenço, RDA; Dhillon, HM; Allen, R; Fontela, A; Kaur, B; Emmett, L; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), |
| 2019-12 | Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan | Lo, SN; Hong, AM; Haydu, LE; Ahmed, T; Paton, EJ; Steel, V; Hruby, G; Tran, A; Morton, RL; Nowak, AK; Vardy, JL; Drummond, KJ; Dhillon, HM; Mandel, C; Scolyer, RA; Middleton, MR; Burmeister, BH; Thompson, JF; Fogarty, GB |
